Data updated: Mar 10, 2026
HYDROCODONE BITARTRATE AND IBUPROFEN
HYDROCODONE BITARTRATE
Approved 2003-04-11
7
Indications
--
Phase 3 Trials
22
Years on Market
Details
- Status
- Discontinued
- First Approved
- 2003-04-11
- Routes
- ORAL
- Dosage Forms
- TABLET
Companies
Website: ↗
HYDROCODONE BITARTRATE AND IBUPROFEN Approval History
Loading approval history...
What HYDROCODONE BITARTRATE AND IBUPROFEN Treats
7 FDA approvalsOriginally approved for its first indication in 2003 . Covers 7 distinct patient populations.
- Other (7)
Other
(7 approvals)- • Approved indication (Apr 2003)
- • Approved indication (Dec 2003)
- • Approved indication (Mar 2004)
- • Approved indication (Nov 2006)
- • Approved indication (Jun 2010)
- • Approved indication (May 2013)
- • Approved indication (Jun 2016)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
HYDROCODONE BITARTRATE AND IBUPROFEN FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.